Lu L - Search Results

1

Case-control study of aspirin use and risk of pancreatic cancer.

Streicher SA, Yu H, Lu L, Kidd MS, Risch HA. Streicher SA, et al. Among authors: lu l. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1254-63. doi: 10.1158/1055-9965.EPI-13-1284. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24969230 Free PMC article.

2

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H. Lu L, et al. Clin Cancer Res. 2006 Feb 15;12(4):1208-14. doi: 10.1158/1078-0432.CCR-05-1801. Clin Cancer Res. 2006. PMID: 16489075

3

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Lu L, et al. Gynecol Oncol. 2006 Dec;103(3):990-5. doi: 10.1016/j.ygyno.2006.06.006. Epub 2006 Jul 21. Gynecol Oncol. 2006. PMID: 16859738

4

Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Oncol Res. 2007;16(8):395-403. doi: 10.3727/000000006783980892. Oncol Res. 2007. PMID: 17913048

5

Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.

Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. Lu L, et al. Cancer Res. 2007 Nov 1;67(21):10117-22. doi: 10.1158/0008-5472.CAN-07-2544. Cancer Res. 2007. PMID: 17974952

6

IGF-I in epithelial ovarian cancer and its role in disease progression.

Brokaw J, Katsaros D, Wiley A, Lu L, Su D, Sochirca O, de la Longrais IA, Mayne S, Risch H, Yu H. Brokaw J, et al. Among authors: lu l. Growth Factors. 2007 Oct;25(5):346-54. doi: 10.1080/08977190701838402. Growth Factors. 2007. PMID: 18236213

7

Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.

Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Cancer Invest. 2008 Mar;26(2):185-92. doi: 10.1080/07357900701638343. Cancer Invest. 2008. PMID: 18259951

8

Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.

Mu L, Katsaros D, Wiley A, Lu L, de la Longrais IA, Smith S, Khubchandani S, Sochirca O, Arisio R, Yu H. Mu L, et al. Among authors: lu l. Breast Cancer Res Treat. 2009 May;115(1):151-62. doi: 10.1007/s10549-008-0046-x. Epub 2008 May 15. Breast Cancer Res Treat. 2009. PMID: 18481170

9

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.

Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H. Qian B, et al. Among authors: lu l. Breast Cancer Res Treat. 2009 Sep;117(1):131-40. doi: 10.1007/s10549-008-0219-7. Epub 2008 Oct 19. Breast Cancer Res Treat. 2009. PMID: 18932017

10

Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.

Lu L, Katsaros D, Shaverdashvili K, Qian B, Wu Y, de la Longrais IA, Preti M, Menato G, Yu H. Lu L, et al. Eur J Cancer. 2009 Aug;45(12):2212-8. doi: 10.1016/j.ejca.2009.05.003. Epub 2009 May 26. Eur J Cancer. 2009. PMID: 19477633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,827 results

Search Page

Filters